Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 159 | 0.91 |
| pathways Reactome | 3 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 5033
Sealed predictions
- PEX2 in dopamine neurons, braak-0.10 (p 0.790) → +0.51 (p 0.163)receipt 5040
Swarm cases
receipt 5040: PEX2 in dopamine neurons, braak
- power
- full sample +0.24 (p 0.346, n 18), 95% CI -0.26 to +0.63. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.34 (p 0.167, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.33 (p 0.188, n 18). could be the mix.
- skeptic
- leave-one-out range +0.14 to +0.40, sign flips 0; without severely affected donors +0.24 (p 0.346, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PEX2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts